[Surgical solution to vitreous floaters visual problem]

Arch Soc Esp Oftalmol. 2009 May;84(5):259-62. doi: 10.4321/s0365-66912009000500007.
[Article in Spanish]


Purpose: To evaluate the role of 25 gauge pars-plana vitrectomy (25G-PPV), after a careful patient selection, when we find highly annoying vitreous floaters and to question if this is an ethical therapeutic option.

Methods: A retrospective study of eight eyes (seven patients) aged 58+/-14 years old (range 42-78) high myopes and pseudophakes who underwent 25G-PPV. Clinical data and visual acuity were studied at six to twelve months follow-up. Health-related functioning and quality of life was measured with the 39-item National Eye Institute Visual Functioning Questionnaire (NEI VFQ-39).

Results: No complications were observed. All patients were satisfied. Safety at third month was 100% and 37.5% improved one or more lines of visual acuity.

Conclusions: Vitreous floaters can be often undervaluated by ophthalmologists, resulting in no intervention. Conventional 20 gauge PPV after a carefully examination can be an effective option for some authors. 25G-PPV incorporates also advantages as the early recovery, with little complications in pseudophakic eyes.

Publication types

  • Evaluation Study

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Adrenergic beta-Antagonists / therapeutic use
  • Adult
  • Aged
  • Eye Diseases / psychology
  • Eye Diseases / surgery*
  • Female
  • Humans
  • Laser Coagulation
  • Male
  • Middle Aged
  • Ocular Hypertension / complications
  • Ocular Hypertension / drug therapy
  • Ocular Hypotension / complications
  • Ocular Hypotension / drug therapy
  • Patient Satisfaction
  • Pseudophakia / complications
  • Quality of Life
  • Retrospective Studies
  • Surveys and Questionnaires
  • Treatment Outcome
  • Vitrectomy* / ethics
  • Vitrectomy* / methods
  • Vitrectomy* / psychology
  • Vitreous Body / surgery*


  • Adrenal Cortex Hormones
  • Adrenergic beta-Antagonists